The development of both Aβ and tau pathology in AD models depicts their interplay during the development and progression of the disease, thus demonstrating the AD phenotypic alterations in a more comprehensive way (Lewis et al., 2001; Oddo et al., 2003; Boutajangout et al., 2004; Bolmont et al., 2007). Here, MAPT is linked to Alzheimer disease.